PortViewPortView
Turn Therapeutics logo

Turn Therapeutics (TTRX) Stock Analysis

NASDAQHealthcareBiotechnology

$9.13-7.03%
1-year price historyRange $2.71 – $10.54
52-week range$9.13
$2.57$26.50

What Turn Therapeutics does

Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.

Key metrics

Market cap
$271.95M
P/E (TTM)
-31.43
EPS (TTM)
$-0.29
Beta
2.02
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$8.96
200-day avg
$5.22
52-week high
$26.50
52-week low
$2.57
CEO
Bradley E. Burnam

ETFs linked to TTRX

Broad-market and Healthcare sector ETFs an investor holding Turn Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TTRX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TTRX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Turn Therapeutics?
Turn Therapeutics trades under the ticker TTRX on NASDAQ.
Which exchange is TTRX listed on?
TTRX is listed on NASDAQ.
What sector does Turn Therapeutics operate in?
Turn Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TTRX in a portfolio?
PortView shows TTRX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.